Cite
Dabrafenib plus trametinib for compassionate use in metastatic melanoma
MLA
Martín Algarra, Salvador, et al. “Dabrafenib plus Trametinib for Compassionate Use in Metastatic Melanoma.” Medicine, vol. 96, no. 52, Dec. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........00a31f10ffd1f8a1c96ab3b4908621e3&authtype=sso&custid=ns315887.
APA
Martín Algarra, S., Soriano, V., Fernández-Morales, L., Berciano-Guerrero, M.-Á., Mujika, K., Manzano, J. L., Puértolas Hernández, T., Soria, A., Rodríguez-Abreu, D., Espinosa Arranz, E., Medina Martínez, J., Márquez-Rodas, I., Rubió-Casadevall, J., Ortega, M. E., Jurado García, J. M., Lecumberri Biurrun, M. J., Palacio, I., Rodríguez de la Borbolla Artacho, M., Altozano, J. P., … Arance, A. (2017). Dabrafenib plus trametinib for compassionate use in metastatic melanoma. Medicine, 96(52).
Chicago
Martín Algarra, Salvador, Virtudes Soriano, Luis Fernández-Morales, Miguel-Ángel Berciano-Guerrero, Karmele Mujika, José Luis Manzano, Teresa Puértolas Hernández, et al. 2017. “Dabrafenib plus Trametinib for Compassionate Use in Metastatic Melanoma.” Medicine 96 (52). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........00a31f10ffd1f8a1c96ab3b4908621e3&authtype=sso&custid=ns315887.